American College of Toxicology 47th Annual Meeting

Featured Scientific Presentation

Practical Solutions for Streamlined Bioanalysis for Preclinical Studies
Presenters: Staton Wade and Lynn Kamen
Monday, November 16, 2026 
12:00pm-12:55pm
Grand Oaks Ballroom | Level 2, Suite G

Preclinical development demands analytical approaches that are scientifically robust while supporting aggressive timelines. Join Staton Wade and Lynn Kamen as they share practical strategies for streamlining bioanalysis, reducing complexity, and generating reliable data that supports confident decision making throughout preclinical development.

Confident Decisions Begin with Reliable Preclinical Data

The decision to take a molecule into first in human studies is absolutely critical.  Therefore, drug developers rely on preclinical data that is accurate, reproducible, and generated with the right scientific strategy. BioAgilytix partners with pharmaceutical and biotechnology sponsors to develop fit-for-purpose bioanalytical solutions that support toxicology studies, including pharmacokinetic, immunogenicity, and pharmacodynamic measurements across all drug modalities.  

Whether you're selecting. lead clinical candidates or preparing for IND-enabling studies, our scientists help generate the reliable data needed to move programs forward with confidence

Scientific Partnership for Confident Preclinical Development

Every preclinical program presents unique analytical challenges. From selecting the right assay approach to generating data that withstands scientific and regulatory scrutiny, success depends on thoughtful strategy from the beginning.
Meet with our scientific team to discuss practical approaches for:

• Designing fit-for-purpose bioanalytical strategies for preclinical development

• Generating reliable PK, ADA, and biomarker data

• Addressing analytical challenges for complex modalities

• Balancing scientific rigor with accelerated development timelines

• Building analytical strategies that support future clinical success

Scientific Expertise Across the Development Continuum

BioAgilytix partners with sponsors from early discovery through commercialization, delivering integrated bioanalytical expertise across a broad range of therapeutic modalities and analytical platforms.


Our scientific team’s support:

• Pharmacokinetic (PK) Bioanalysis

  • LBA

  • LC-MS

  • Molecular

• Immunogenicity & ADA Assessment

  • LBA

  • Cell-based

• Biomarker Strategy and Testing

  • LBA

  • LC-MS

  • Flow cytometry

  • Molecular

Whether your program requires established methodologies or customized analytical solutions, our scientists collaborate with your team to generate reliable data aligned with your development goals.